Mathew G Miller is a prominent inventor based in San Carlos, California. He has made significant contributions to the field of biochemical engineering, holding a total of 15 patents. His work focuses on engineered ligase variants and human alpha-galactosidase variants, showcasing his expertise in developing innovative solutions for diagnostic and therapeutic applications.

Latest Patents

One of his latest patents involves engineered ligase variants. This invention provides engineered ligase polypeptides and compositions, along with polynucleotides encoding these engineered ligase polypeptides. The invention also outlines methods for utilizing these compositions for diagnostic and other purposes. Another notable patent is related to human alpha-galactosidase variants. This invention presents engineered human alpha-galactosidase polypeptides that have been optimized for improved stability under both acidic and basic conditions. The compositions comprising these engineered polypeptides are intended for therapeutic applications.

Career Highlights

Throughout his career, Mathew has worked with notable companies such as Codexis, Inc. and Crosswalk Therapeutics, Inc. His experience in these organizations has allowed him to further develop his innovative ideas and contribute to advancements in the field.

Collaborations

Mathew has collaborated with several professionals in his field, including Gjalt W Huisman and Oscar Alvizo. These collaborations have enriched his work and expanded the impact of his inventions.

Conclusion

Mathew G Miller is a distinguished inventor whose work in biochemical engineering has led to significant advancements in the development of engineered polypeptides. His contributions continue to influence the fields of diagnostics and therapeutics, making him a key figure in innovation.

This text is generated by artificial intelligence and may not be accurate.